Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular changes in boric acid-treated DU-145 prostate cancer cells.

W T Barranco1, C D Eckhert

  • 1Department of Environmental Health Sciences, University of California, Los Angeles, Box 951770, CA 90095-1772, USA.

British Journal of Cancer
|February 24, 2006
PubMed
Summary

Boric acid, a form of boron, alters prostate cancer cells, reducing their spread, volume, and metastatic potential. These changes suggest boron may inhibit cancer progression by inducing a senescent-like state.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evaluation of reproductive toxicity studies and data interpretation of N-methylpyrrolidone for risk assessment: An expert panel review.

Regulatory toxicology and pharmacology : RTP·2023
Same author

Boron stimulates yeast (Saccharomyces cerevisiae) growth.

The Journal of nutrition·1999
Same author

The response of trout and zebrafish embryos to low and high boron concentrations is U-shaped.

Biological trace element research·1999
Same author

Boron stimulates embryonic trout growth.

The Journal of nutrition·1998
Same author

Parenteral nutrition is associated with intestinal morphologic and functional changes in humans.

JPEN. Journal of parenteral and enteral nutrition·1995
Same author

Photoreceptor damage following exposure to excess riboflavin.

Experientia·1993

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Epidemiological, animal, and cell culture studies suggest boron acts as a chemopreventative agent against prostate cancer.
  • The DU-145 human prostate cancer cell line is a relevant model for studying these effects.

Purpose of the Study:

  • To investigate the specific cellular changes induced by boric acid in the DU-145 human prostate cancer cell line.
  • To understand the mechanisms underlying boron's potential chemopreventative effects.

Main Methods:

  • Prolonged exposure of DU-145 cells to pharmacologically relevant levels of boric acid.
  • Morphological analysis, assessment of beta-galactosidase activity, and quantification of cyclins A-E and MAPK proteins.
  • Evaluation of cell adhesion, migration, invasion, F-actin content, and lysosomal compartments.

Related Experiment Videos

Main Results:

  • Boric acid induced morphological changes including increased granularity, vesicle content, cell spreading, and decreased cell volume.
  • Increased beta-galactosidase activity indicated a senescent-like cellular phenotype.
  • Dose-dependent reduction in cyclins A-E and MAPK proteins, decreased cell adhesion, migration, invasion, and altered F-actin polymerization.
  • Media acidosis correlated with accumulation of LAMP-2-negative acidic compartments.

Conclusions:

  • Boric acid induces significant morphological and functional alterations in DU-145 prostate cancer cells.
  • These changes suggest boric acid may inhibit cancer cell proliferation and reduce metastatic potential.
  • Further research is needed to elucidate the precise molecular mechanisms driving these boron-induced cellular responses.